Esposito M, Grusovin M G, Coulthard P, Worthington H V
School of Dentistry, University of Manchester, Oral and Maxillofacial Surgery, Higher Cambridge Street, Manchester, UK M15 6FH. E-mail:
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004970. doi: 10.1002/14651858.CD004970.pub2.
One of the key factors for the long-term success of oral implants is the maintenance of healthy tissues around them. Bacterial plaque accumulation induces inflammatory changes in the soft tissues surrounding oral implants and it may lead to their progressive destruction (perimplantitis) and ultimately to implant failure. Different treatment strategies for perimplantitis have been suggested, however it is unclear which are the most effective.
To identify the most effective interventions for treating perimplantitis around osseointegrated dental implants.
We searched the Cochrane Oral Health Group's Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and EMBASE. Handsearching included several dental journals. We checked the bibliographies of the identified randomised controlled trials (RCTs) and relevant review articles for studies outside the handsearched journals. We wrote to authors of all identified RCTs, to more than 55 oral implant manufacturers and an Internet discussion group to find unpublished or ongoing RCTs. No language restrictions were applied. The last electronic search was conducted on 15 March 2006.
All RCTs of oral implants comparing agents or interventions for treating perimplantitis around dental implants.
Screening of eligible studies, assessment of the methodological quality of the trials and data extraction were conducted in duplicate and independently by two review authors. We contacted the authors for missing information. Results were expressed as random-effects models using weighted mean differences for continuous outcomes and risk ratios for dichotomous outcomes with 95% confidence intervals (CI). Heterogeneity was to be investigated including both clinical and methodological factors.
Seven eligible trials were identified, but two were excluded. The following procedures were tested: 1) use of local antibiotics versus ultrasonic debridement; 2) benefits of adjunctive local antibiotics to debridement; 3) different techniques of subgingival debridement; 4) laser versus manual debridement and chlorhexidine irrigation/gel; 5) systemic antibiotics plus resective surgery plus two different local antibiotics with and without implant surface smoothening. Follow up ranged from 3 months to 2 years. No meta-analysis was conducted due to different interventions tested and outcomes used. No side effects occurred in any of the trials. The only significant statistically differences were observed in a 4-month follow-up RCT evaluating the use of adjunctive local antibiotics to manual debridement in patients having lost at least 50% of the supporting bone around the implants. There were improved probing attachment levels (PAL) mean differences of 0.61 mm (95% CI 0.40 to 0.82), and reduced probing pockets depths (PPD) mean differences of 0.59 mm (95% CI 0.39 to 0.79) in those patients receiving adjunctive local antibiotics. This trial was judged to be at high risk of bias.
AUTHORS' CONCLUSIONS: There is no reliable evidence suggesting which could be the most effective interventions for treating perimplantitis. This is not to say that currently used interventions are not effective. However, the use of local antibiotics in addition to manual subgingival debridement was associated with a 0.6 mm additional improvement for PAL and PPD over a 4-month period in patients associated with severe forms of perimplantitis. In three trials, the control therapy which basically consisted of a simple subgingival mechanical debridement seemed to be sufficient to achieve results similar to the more complex and expensive therapies. Smoothening of rough implant surfaces was not associated with statistically significant improvements of the clinical outcomes. However, sample sizes were small, therefore these conclusions have to be considered with great caution. More well-designed RCTs are needed.
口腔种植体长期成功的关键因素之一是维持其周围健康的组织。细菌菌斑的堆积会引起口腔种植体周围软组织的炎症变化,并可能导致其逐渐破坏(种植体周炎),最终导致种植失败。针对种植体周炎已提出了不同的治疗策略,但尚不清楚哪种最为有效。
确定治疗骨结合牙种植体周围种植体周炎的最有效干预措施。
我们检索了Cochrane口腔健康小组试验注册库、Cochrane对照试验中央注册库(CENTRAL)、MEDLINE和EMBASE。手工检索包括几本牙科杂志。我们检查了已识别的随机对照试验(RCT)的参考文献以及相关综述文章,以查找手工检索杂志之外的研究。我们致函所有已识别的RCT的作者、55多家口腔种植体制造商以及一个互联网讨论组,以查找未发表或正在进行的RCT。未设语言限制。最后一次电子检索于2006年3月15日进行。
所有比较治疗牙种植体周围种植体周炎的药物或干预措施的口腔种植体RCT。
两名综述作者独立重复进行合格研究的筛选、试验方法学质量评估和数据提取。我们就缺失信息与作者进行了联系。结果以随机效应模型表示,连续结局采用加权均数差,二分结局采用风险比,并给出95%置信区间(CI)。将对异质性进行调查,包括临床和方法学因素。
共识别出7项合格试验,但排除了2项。测试了以下程序:1)局部使用抗生素与超声清创术;2)辅助局部抗生素清创的益处;3)龈下清创的不同技术;4)激光与手动清创及洗必泰冲洗/凝胶;5)全身使用抗生素加切除性手术加两种不同的局部抗生素,有或无种植体表面光滑处理。随访时间为3个月至2年。由于测试的干预措施和使用的结局不同,未进行荟萃分析。所有试验均未出现副作用。在一项为期4个月的RCT中观察到唯一显著的统计学差异,该试验评估了在种植体周围至少50%的支持骨丧失的患者中辅助局部抗生素与手动清创联合使用的效果。接受辅助局部抗生素治疗的患者,探诊附着水平(PAL)平均改善0.61mm(95%CI 0.40至0.82),探诊袋深度(PPD)平均减少0.59mm(95%CI 0.39至0.79)。该试验被判定存在高偏倚风险。
没有可靠证据表明哪种干预措施对治疗种植体周炎最有效。这并不是说目前使用的干预措施无效。然而,对于患有严重种植体周炎的患者,除手动龈下清创外使用局部抗生素在4个月内使PAL和PPD额外改善了0.6mm。在三项试验中,基本由简单龈下机械清创组成的对照治疗似乎足以取得与更复杂、更昂贵治疗相似的结果。粗糙种植体表面的光滑处理与临床结局的统计学显著改善无关。然而,样本量较小,因此这些结论必须谨慎对待。需要更多设计良好的RCT。